BioLargo (BLGO) Competitors $0.22 +0.01 (+4.95%) As of 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BLGO vs. AMTX, VGAS, FSI, LOOP, ZTEK, ALTO, LODE, TSE, ORGN, and CBUSShould you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Flexible Solutions International (FSI), Loop Industries (LOOP), Zentek (ZTEK), Alto Ingredients (ALTO), Comstock (LODE), Trinseo (TSE), Origin Materials (ORGN), and Cibus (CBUS). These companies are all part of the "chemicals" industry. BioLargo vs. Its Competitors Aemetis Verde Clean Fuels Flexible Solutions International Loop Industries Zentek Alto Ingredients Comstock Trinseo Origin Materials Cibus Aemetis (NASDAQ:AMTX) and BioLargo (NASDAQ:BLGO) are both small-cap chemicals companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk. Do analysts recommend AMTX or BLGO? Aemetis presently has a consensus target price of $17.00, indicating a potential upside of 662.33%. Given Aemetis' stronger consensus rating and higher probable upside, equities research analysts clearly believe Aemetis is more favorable than BioLargo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aemetis 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer AMTX or BLGO? In the previous week, Aemetis and Aemetis both had 2 articles in the media. BioLargo's average media sentiment score of 1.46 beat Aemetis' score of 0.64 indicating that BioLargo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aemetis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLargo 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is AMTX or BLGO more profitable? BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.70%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.Company Net Margins Return on Equity Return on Assets Aemetis-36.70% N/A -33.18% BioLargo -11.45%-39.90%-22.06% Do institutionals & insiders believe in AMTX or BLGO? 27.0% of Aemetis shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 15.9% of Aemetis shares are held by insiders. Comparatively, 19.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, AMTX or BLGO? Aemetis has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500. Which has preferable earnings and valuation, AMTX or BLGO? BioLargo has lower revenue, but higher earnings than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAemetis$267.64M0.53-$87.54M-$1.62-1.38BioLargo$12.23M5.68-$3.50M-$0.01-22.46 SummaryAemetis beats BioLargo on 8 of the 15 factors compared between the two stocks. Get BioLargo News Delivered to You Automatically Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLGO vs. The Competition Export to ExcelMetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ ExchangeMarket Cap$69.45M$11.87B$9.42B$10.27BDividend YieldN/A1.09%1.85%4.60%P/E Ratio-22.46N/A17.1426.41Price / Sales5.683.9396.2788.61Price / CashN/A14.8015.3729.91Price / Book22.4612.674.736.28Net Income-$3.50M$989.69M$618.77M$270.38M7 Day Performance9.03%4.51%0.09%2.70%1 Month Performance26.89%13.45%8.29%5.99%1 Year Performance-7.57%-3.79%107.08%25.94% BioLargo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLGOBioLargo0.9831 of 5 stars$0.22+5.0%N/A-11.9%$69.45M$12.23M-22.4630News CoveragePositive NewsShort Interest ↓Gap UpAMTXAemetis1.8445 of 5 stars$2.23-1.3%$17.00+662.3%-10.7%$142.93M$267.64M-1.38160VGASVerde Clean Fuels0.2375 of 5 stars$3.09+8.0%N/A-26.4%$127.41MN/A-7.542Positive NewsGap UpFSIFlexible Solutions International3.9403 of 5 stars$9.73+1.5%N/A+187.3%$121.38M$37.32M29.4940Positive NewsShort Interest ↑LOOPLoop Industries1.494 of 5 stars$1.97-4.4%N/A+32.2%$98.30M$10.89M-7.0490High Trading VolumeZTEKZentek0.8434 of 5 stars$0.89+2.9%N/A+16.1%$90.06M$1.22M-17.7024Short Interest ↓ALTOAlto Ingredients3.1264 of 5 stars$1.16+1.8%$5.50+374.1%-23.4%$88.23M$965.26M-1.26420LODEComstock1.5336 of 5 stars$2.43+0.4%$4.00+64.6%-8.6%$87.31M$3.28M-20.2530Positive NewsTSETrinseo0.7632 of 5 stars$2.42+0.8%N/A-41.0%$86.29M$3.51B-0.222,950ORGNOrigin Materials2.4961 of 5 stars$0.52-1.0%$1.50+186.4%-63.6%$79.30M$31.28M-0.84160News CoveragePositive NewsCBUSCibus2.5591 of 5 stars$1.41+8.5%$22.00+1,460.3%-75.2%$70.51M$4.85M-0.1348Positive NewsHigh Trading Volume Related Companies and Tools Related Companies AMTX Competitors VGAS Competitors FSI Competitors LOOP Competitors ZTEK Competitors ALTO Competitors LODE Competitors TSE Competitors ORGN Competitors CBUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLGO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLGO Stock Alerts